Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Papillomavirus Infections 1Neoplasms 1Multiple Myeloma 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Financial Stress 1Esophageal Neoplasms 1Breast Neoplasms 1

Interventions

Specimen Handling 5Human Papillomavirus Recombinant Vaccine nonavalent 4Papillomavirus Vaccines 3Human Papillomavirus DNA Tests 3Colposcopy 3Radiotherapy, Intensity-Modulated 2Methods 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Early Intervention, Educational 2Cisplatin 2human papillomavirus vaccine, L1 type 16, 18 1artesunic acid 1artenimol 1artemisinin 1adacel 1Vaccines 1Tetanus Toxoid 1Sodium Chloride 1Platinum 1Patient Navigation 1Nimorazole 1Mass Screening 1Interviews as Topic 1Injections 1High-Energy Shock Waves 1Educational Status 1Diphtheria-Tetanus-acellular Pertussis Vaccines 1Diphtheria Toxoid 1Clinical Protocols 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Papillomavirus Infections × Mass Screening × Clear all
NCT04965792 2025-06-17

Post-treatment Surveillance in HPV+ Oropharyngeal SCC

Dana-Farber Cancer Institute

Active not recruiting
150 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡